JG
EFTRW

Jefferies Group’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Jefferies Group’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.03K Hold
10,000
– – ﹤0.01% 1587
2022
Q2 		$2.5K Hold
10,000
– – ﹤0.01% 1495
2022
Q1 		$4.3K Hold
10,000
– – ﹤0.01% 1489
2021
Q4 		$8.8K Hold
10,000
– – ﹤0.01% 1576
2021
Q3 		$16K Buy
+10,000
New +$12.1K ﹤0.01% 1648

Other funds holding EFTRW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
ECM
Evolution Capital Management Crystal Bay, Nevada $29M AUM 2.56% 1-Year Est. Return
ICM
III Capital Management Boca Raton, Florida $344M AUM 11.22% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jefferies Group's EFTRW Position: Q3 2022 in Review

Jefferies Group held its eFFECTOR Therapeutics, Inc. Warrant (EFTRW) position steady in Q3 2022 at 10,000 shares worth $2.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1587.

Jefferies Group first reported a position in EFTRW in Q3 2021 and has held it in 5 quarters since. The position peaked at $16K in Q3 2021. 12 funds tracked by Wall St. Rank hold EFTRW as of Q3 2022.

  • Jefferies Group held 10,000 shares of eFFECTOR Therapeutics, Inc. Warrant worth $2.03K as of Q3 2022.
  • Jefferies Group left its eFFECTOR Therapeutics, Inc. Warrant share count unchanged in Q3 2022.
  • eFFECTOR Therapeutics, Inc. Warrant made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1587 holding.
  • Jefferies Group first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q3 2021 and has held it in 5 quarters since.
  • Jefferies Group's eFFECTOR Therapeutics, Inc. Warrant position peaked at $16K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.